Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Calendar
  • Grants
  • About Akademiliv

OligoNova HUB – Innovative Development of a New Class of Drugs

22 April, 2022 Leave a Comment

INFRASTRUCTURE. OligoNova Hub is Sweden’s new national infrastructure for drug development, specifically focused on therapeutic oligonucleotides. Here, researchers with expertise in e.g. bioinformatics, chemistry and cellular biology will work with innovative development projects of drugs for patient groups that currently lack appropriate treatment.

Pär Matsson, professor of pharmacokinetics at the Department of Pharmacology, Sahlgrenska Academy, is head of the OligoNova Hub.

Pär Matsson, professor vid Department of Pharmacology
at the Institute of Neuroscience and Physiology. Photo: Josefin Bergenholtz.

“My research focuses on drug development, especially how to optimize new classes of drugs so that they reach the specific cells and targets that they are intended to affect. OligoNova Hub’s focus is in-line with my research expertise, and it feels very exciting to be involved in building a national pharmaceutical infrastructure from scratch,” Pär said.

Resource and competence in drug development

The OligoNova HUB’s mission is to support academic research with resources and expertise in the field of drug development.

“Our goal is to help researchers convert their research results into new drugs for patient groups that currently lack appropriate treatment.”

In the first phase, the hub will consist of 8-10 employees, but in the long term, additional team members are to be recruited.

Cooperation Between University and Industry

The hub is organizationally part of Core Facilities at the University of Gothenburg. At the same time, it is part of SciLifeLab’s national drug platform (DDD) and is located in AstraZeneca’s BioVentureHub in Mölndal.

Pär Matsson emphasized that this will enable a broad and important collaboration between universities and industry – which is central to continued world-leading pharmaceutical research in Sweden.

“AstraZeneca have the past years invested in the development of therapeutic oligonucleotides. Now that OligoNova Hub is co-located with AstraZeneca in Mölndal, there will naturally be opportunities for collaboration and for productive discussions with their experts in the field.”

Within the Core Facilities platforms, expertise that is central to drug development projects at OligoNova Hub are already available, for example in areas like proteomics, imaging, bioinformatics, protein production and genomics. Pär also mentions that the Swedish NMR Centre is located nearby at GU, which also gives a great advantage.

“As a newly started platform, we can both use established expertise, instruments and existing project flows, while at the same time contribute to adding new technology and a new class of drugs to the research,” Pär said.

Call for therapeutic oligonucleotide projects

In a call for projects, the HUB is currently looking for project ideas for new therapeutic oligonucleotides. The call is open for scientists with a doctoral degree at a Swedish university or higher institution.

 

READ FURTHER

  • OligoNova Hub
  • Oligonova.org
  • News article about the first face-to-face OligoNova Network conference: OligoNova sets up first gathering of top Swedish oligonucleotide scientists

BY: CHARBEL SADER

By: Elin Lindström
Tagged With: institutionen för neurovetenskap och fysiologi

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Add your own events in the Akademiliv Calendar

The Akademiliv newsletter has paused for summer. In the autumn, you will receive the first regular newsletter on August 24th.

Collected links regarding the war in Ukraine

We are building at Medicinareberget

You will now find comprehensive information on construction projects that affect the Sahlgrenska Academy in the Staff Portal.

Lunch menus

Café & restaurang Anatomen

Gastronomen på SU

Lunchen.nu

Lyktan lunchservering

Lustgården på Änggårdsbacken

Café Anne Dahl

More news

Summer wishes from Dean Agneta Holmäng

23 June, 2022

CHRONICLE. In her last letter to staff and students this semester, Agneta Holmäng focuses especially on two matters that caused a big flurry of …  

The University’s work with research areas

22 June, 2022

PROFILE AREAS. Which areas should be designated as special research areas at the University of Gothenburg? This issue will be investigated in the …  

See Natrium from the inside – open tour September 30

22 June, 2022

The construction project invites staff and students at the Faculty of Science and Sahlgrenska Academy on September 30 in the afternoon. With less …  

Magnet makes life science research visible at the Swedish NMR centre

21 June, 2022

CONDITIONS OF RESEARCH. Outside the Swedish NMR Centre, at the Hasselblad laboratory on Medicinareberget, a large magnet has recently been set …  

Nominate members to the consultative assembly for election of a vice-chancellor

20 June, 2022

VICE-CHANCELLOR ELECTION. Sahlgrenska Academy will appoint 13 members to the consultative assembly, which is preparing the appointment of a …  

Stem cells can become a treatment for common joint disease

20 June, 2022

RESEARCH COOPERATION. In the future, it is hoped that stem cells can be used to treat osteoarthritis, the world’s most common joint disease. R …  

Innovation from within when Vinnova visited Gothenburg

20 June, 2022

INTERACTION. Life science and collaboration among the medical system, academia, and the private sector was the main theme when Vinnova, Sweden’s i …  

Protein Research: Increased Access to Knowledge and Support

16 June, 2022

CONDITIONS OF RESEARCH. With Protein Production Sweden (PPS), a new national infrastructure has taken shape. Expression, production and …  

New episode of the Swedish podcast Akademiliv – with diabetes researcher Emanuel Fryk

16 June, 2022

PODCAST. Guest in this episode of the podcast Akademiliv is Emanuel Fryk, a doctoral student at the University of Gothenburg and a doctor at a …  

Primary hyperparathyroidism linked to bone fracture, stroke, and heart attack

16 June, 2022

NEW STUDY. In the hormonal disorder primary hyperparathyroidism, patients’ risk of hip fracture is elevated by 51%, and that of heart attack or s …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen